Filtered By:
Condition: Atrial Fibrillation
Countries: Jordan Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 78 results found since Jan 2013.
Pharmacotherapy for Patients With Atrial Fibrillation and Cerebral Microbleeds
Background: Patients with cerebral microbleeds have increased risk of intracranial hemorrhage and ischemic stroke. No trial specifically informs antithrombotic therapy for patients with cerebral microbleeds and atrial fibrillation. We investigated the safety of anticoagulation versus no anticoagulation with regard to cerebrovascular outcomes and mortality. Methods: All consecutive atrial fibrillation patients from 2015 to 2018 with MRI evidence of ≥1 cerebral microbleed at time of imaging were reviewed.
Source: Journal of Stroke and Cerebrovascular Diseases - May 14, 2019 Category: Neurology Authors: Mohammed K. Badi, George K. Vilanilam, Vivek Gupta, Kevin M. Barrett, Elizabeth R. Lesser, Jordan J. Cochuyt, David O. Hodge, Thomas G. Brott, James F. Meschia Source Type: research
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
CONCLUSIONS: This study of Middle Eastern AF patients has reported high adherence to OACs. The use of OACs was associated with a lower risk for all-cause mortality. One-year rates of stroke and major bleeding events were comparable to those reported from other regions in the world.PMID:35462945 | PMC:PMC9020983 | DOI:10.1155/2022/4240999
Source: International Journal of Vascular Medicine - April 25, 2022 Category: Cardiology Authors: Ayman Hammoudeh Yousef Khader Ramzi Tabbalat Yahya Badaineh Nazih Kadri Haneen Shawer Eyas Al-Mousa Rasheed Ibdah Batool A Shawer Imad A Alhaddad Source Type: research
